It used to be that sacrificing one's own health was not an option. So now new responsibility has emerged for marketers.
PRESIDENT AND CEO | HC&B HEALTHCARE COMMUNICATIONS
It used to be that sacrificing one's own health was not an option. So now new responsibility has emerged for marketers. A new heightened need to educate is here. What are the benefits of sticking to your regimen? What are the dangers of stopping? How can you prioritize your lifestyle to put healthcare first? This dialogue can best be facilitated via the Web with accountability diaries that reward compliance or provide discounts. It's our responsibility to educate and encourage with new kinds of innovative communications.
Kerry Hilton
A much more stringent review of online messaging is most likely coming. Various rules will apply for display ads, rich media ads, banners, etc., depending on the real estate they occupy. I personally would like to see the industry step forward and lead this discussion with recommended guidelines now. This proactive approach will define the future rather than have it defined for us. Why not partner with Google? Let's merge together the future of online health with online health marketing.
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.